For the treatment of chronic wounds, acid-oxidizing solutions (AOSs) with broad-spectrum microbicidal activity without disturbing granulation tissue formation have been developed. We found AOSs to efficiently kill Mycobacterium ulcerans, the causative agent of Buruli ulcer, which is able to survive harsh decontamination treatments. Topical AOS treatment of Buruli ulcer lesions may support the recommended antibiotic therapy (oral rifampin and clarithromycin), prevent contamination of the environment by the mycobacteria, and control secondary infections, which are a prevalent wound management problem in resource-poor settings where Buruli ulcer is endemic.
CITATION STYLE
Warryn, L., & Pluschke, G. (2022). Efficacy of an Acid-Oxidizing Solution against Mycobacterium ulcerans. Antimicrobial Agents and Chemotherapy, 66(1). https://doi.org/10.1128/AAC.00870-21
Mendeley helps you to discover research relevant for your work.